欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0412/001
药品名称Parofor 140 mg/ml
活性成分
    • PAROMOMYCIN SULFATE 200.0 mg/ml
剂型Oral solution
上市许可持有人Huvepharma NV Uitbreidingstraat 80 2600 Antwerpen Belgium
参考成员国 - 产品名称Ireland (IE)
Parofor
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
      Parofor
    • Belgium (BE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Parofor crypto 140 000 IE/ml Lösung zum Eingeben für Schafe und Ziegen
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
      Parofor crypto 140 000 IU/ml šķīdums iekšķīgai lietošanai aitām un kazām
    • Lithuania (LT)
      Parofor crypto 140000 TV/ML, geriamasis tirpalas avims ir ožkoms
    • Estonia (EE)
      Parofor crypto
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
      Parofor crypto 140 000 IU/ml perorální roztok pro ovce a kozy
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
许可日期2019/04/18
最近更新日期2024/01/26
药物ATC编码
    • QA07AA06 paromomycin
申请类型
  • TypeLevel1：food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase